ASX Growth Stocks With High Insider Ownership August 2026
As the Australian market navigates a period of uncertainty with the S&P/ASX 200 recently dipping below its 20-day moving average, investors are keenly observing how local stocks respond to global influences such as rising Wall Street indices and fluctuating oil prices. In this climate, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the business and may offer resilience amidst broader market volatility.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Wisr (ASX:WZR) | 10.2% | 88.3% |
| Titomic (ASX:TTT) | 14.7% | 71.3% |
| Starpharma Holdings (ASX:SPL) | 19.3% | 89.5% |
| SKS Technologies Group (ASX:SKS) | 28.2% | 27.7% |
| Predictive Discovery (ASX:PDI) | 10.4% | 63.6% |
| Forrestania Resources (ASX:FRS) | 32.3% | 126.7% |
| Austral Resources Australia (ASX:AR1) | 22.9% | 36.6% |
| Auric Mining (ASX:AWJ) | 19.7% | 29.2% |
| Adveritas (ASX:AV1) | 17.6% | 107.8% |
| Advanced Engineered Materials (ASX:AEM) | 35.1% | 48.5% |
We'll examine a selection from our screener results.
Aurelia Metals (ASX:AMI)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Aurelia Metals Limited is an Australian company involved in the exploration and production of mineral properties, with a market cap of A$677.36 million.
Operations: Aurelia Metals Limited generates its revenue primarily through the exploration and production of mineral properties in Australia.
Insider Ownership: 28.2%
Earnings Growth Forecast: 21.3% p.a.
Aurelia Metals is poised for significant growth, with earnings expected to increase by 21.3% annually over the next three years, outpacing the Australian market's 12.2%. Despite a slower revenue growth forecast of 7.4%, it still exceeds the market average of 5.6%. Trading at A$31.6% below its estimated fair value, Aurelia offers potential upside for investors seeking undervalued opportunities in Australia’s mining sector without recent insider trading activity influencing stock dynamics.
- Click here to discover the nuances of Aurelia Metals with our detailed analytical future growth report.
- The analysis detailed in our Aurelia Metals valuation report hints at an deflated share price compared to its estimated value.
Regis Healthcare (ASX:REG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Regis Healthcare Limited provides residential aged care services in Australia and has a market cap of A$1.93 billion.
Operations: The company generates revenue of A$1.26 billion from residential aged care, home care, and retirement living services in Australia.
Insider Ownership: 38.6%
Earnings Growth Forecast: 19.2% p.a.
Regis Healthcare is set for growth, with revenue projected to rise by 8.3% annually, surpassing the Australian market's 5.6%. Its earnings are forecast to grow at 19.2% per year, exceeding the market average of 12.2%, though not significantly high. The stock trades at a substantial discount of 77.9% below its fair value estimate, yet its dividend yield of 2.82% isn't well-covered by earnings. Recent executive changes may influence future strategic directions.
- Take a closer look at Regis Healthcare's potential here in our earnings growth report.
- The valuation report we've compiled suggests that Regis Healthcare's current price could be quite moderate.
Starpharma Holdings (ASX:SPL)
Simply Wall St Growth Rating: ★★★★★★
Overview: Starpharma Holdings Limited is a biopharmaceutical company focused on the research, development, and commercialization of dendrimer technology for pharmaceutical and healthcare applications in Australia and internationally, with a market cap of A$362.56 million.
Operations: The company generates revenue of A$14.58 million from its activities in the discovery, development, and commercialization of dendrimers.
Insider Ownership: 19.3%
Earnings Growth Forecast: 89.5% p.a.
Starpharma Holdings demonstrates promising growth potential, with revenue expected to increase by 39.5% annually, significantly outpacing the Australian market's average. Earnings are projected to grow at a very high rate of 89.5% per year, and the company is anticipated to achieve profitability within three years. Insider confidence is strong, evidenced by substantial insider buying recently and no significant selling activity. The stock trades considerably below its estimated fair value following recent equity offerings totaling A$31.99 million.
- Delve into the full analysis future growth report here for a deeper understanding of Starpharma Holdings.
- The analysis detailed in our Starpharma Holdings valuation report hints at an inflated share price compared to its estimated value.
Make It Happen
- Investigate our full lineup of 101 Fast Growing ASX Companies With High Insider Ownership right here.
- Want To Explore Some Alternatives? Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com